Caralyn Digangi is a Commack, New York based nurse practitioner. Active license number of Caralyn Digangi is 307596 for Adult Health in New York. Her current practice location is 6277 Jericho Tpke, Commack. Patients can reach her at 631-462-6644. Caralyn Digangi is NP and her NPI number (Unique professional ID assigned by NPPES) is 1033593017. Caralyn Digangi has completed additional training beyond basic nursing education and provides primary health care services in accordance with state nurse practice laws or statutes. NPs are trained to assess patient needs, order and interpret diagnostic and laboratory tests, diagnose disease, formulate and prescribe medications and treatment plans.
Complete Profile:
Caralyn Digangi speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1033593017
NPI Enumeration Date:
19 Jul, 2015
NPI Last Update On:
08 May, 2016
Medical Licenses:
NPs can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Caralyn Digangi are as mentioned below.
License Number
Specialization
State
Status
307596
Adult Health
New York
Primary
659540
Registered Nurse
New York
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Caralyn Digangi 6277 Jericho Tpke, Commack, New York
Zip:
11725-2837
Phone Number:
631-462-6644
Patients can reach Caralyn Digangi at 6277 Jericho Tpke, Commack, New York or can call to book an appointment on 631-462-6644.
Comments/ Reviews:
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 13 January, 2025.